Singapore: HPS2-THRIVE (heart protection study 2-treatment of HDL to reduce the incidence of vascular events) study of T...
Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client deman...
Singapore: Bionomics has been advised by its licensee, Ironwood Pharmaceuticals, that following the submission of an In...
Singapore: Australia's Therapeutic Goods Administration (TGA) has identified errors in its internal reports regarding t...
Singapore: Japanese drugmaker Mitsubishi Tanabe Pharma Corporation (MTPC) and Canada-based Medicago, a clinical-stage bi...
Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate contro...
New Zealand's Health Committee submitted a 62-page report to New Zealand's Parliament making necessary recommendations t...
China's role in the global drug industry will fundamentally change; most companies will fail to capitalize on this oppor...
Singapore: Siro Clinpharm, a leading full service clinical research organization, has deployed one-of-the-biggest IT ad...
Singapore: The Skin Research Institute of Singapore has announced that the Agency for Science Technology and Research (A...
Singapore: Therapeutically focused global clinical research organization, INC Research LLC has announced the establishme...
Singapore: Spinifex Pharmaceuticals, an Australian pain drug development company, revealed positive headline results fr...
In a study that analyzed reports from large clinical trials (more than 500 participants), registered on ClinicalTrials.g...
Singapore: Quintiles founder Dr Dennis Gillings has received the SCRIP 'Lifetime Achievement Award' and the company has ...
Singapore: BHR Pharma has reached its SyNAPSe clinical trial enrollment midpoint of 590 patients. The company made the a...
Singapore: A new Economist Intelligence Unit (EIU) report sponsored by Quintiles concludes that "China is a complex mark...
Singapore: Pharmaceutical Product Development's (PPD) site has been acknowledged by CenterWatch's 2013 Global Investigat...
Singapore: The early development facility of Covance, which is located in Shanghai, China, received a good laboratory pr...
